Northern Trust’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,436
| Closed | -$9.5K | – | 4580 |
|
|
2022
Q4 | $9.5K | Hold |
1,436
| – | – | ﹤0.01% | 4580 |
|
|
2022
Q3 | $19K | Hold |
1,436
| – | – | ﹤0.01% | 4553 |
|
|
2022
Q2 | $22K | Sell |
1,436
-24
| -2% | -$368 | ﹤0.01% | 4607 |
|
|
2022
Q1 | $54K | Sell |
1,460
-288
| -16% | -$10.7K | ﹤0.01% | 4515 |
|
|
2021
Q4 | $100K | Sell |
1,748
-22
| -1% | -$1.26K | ﹤0.01% | 4424 |
|
|
2021
Q3 | $181K | Buy |
1,770
+143
| +9% | +$14.6K | ﹤0.01% | 4219 |
|
|
2021
Q2 | $159K | Sell |
1,627
-3,659
| -69% | -$358K | ﹤0.01% | 4231 |
|
|
2021
Q1 | $539K | Sell |
5,286
-385
| -7% | -$39.3K | ﹤0.01% | 3793 |
|
|
2020
Q4 | $559K | Sell |
5,671
-230
| -4% | -$22.7K | ﹤0.01% | 3698 |
|
|
2020
Q3 | $2.84M | Buy |
5,901
+358
| +6% | +$172K | ﹤0.01% | 2876 |
|
|
2020
Q2 | $4.3M | Buy |
5,543
+1,484
| +37% | +$1.15M | ﹤0.01% | 2611 |
|
|
2020
Q1 | $2.82M | Buy |
4,059
+89
| +2% | +$61.9K | ﹤0.01% | 2652 |
|
|
2019
Q4 | $3.64M | Buy |
+3,970
| New | +$3.64M | ﹤0.01% | 2778 |
|